2026 · 2nd Quarter (Apr 1 - June 30)

INDEPENDENT PHARMACY COOPERATIVE

Filed by FORBES-TATE.

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 20, 2026
Income: $40,000.00
Expenses: Not reported
Registrant: FORBES-TATE
Client: INDEPENDENT PHARMACY COOPERATIVE
Filing UUID: b4a8e6b7-8251-41be-bd83-13f7ff95e461
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Main Street Pharmacy Act.

Literal federal measure citations: S. 891, S. 927, H.R. 4317, S. 2426, H.R. 3164

PHA · Pharmacy

Literal federal measure citations: S. 891, S. 927, H.R. 4317, S. 2426, H.R. 3164

MMM · Medicare/Medicaid

Literal federal measure citations: S. 891, S. 927, H.R. 4317, S. 2426

BUD · Budget/Appropriations

Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation Program in the One Big Beautiful Bill Act (P.L. 119-21).

CSP · Consumer Issues/Safety/Products

Issues related to S.3822 - Break Up Big Medicine Act.

Literal federal measure citations: S.3822

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.